Article Versions Notes

Gong J, Osipov A, Lorber J, Tighiouart M, Kwan AK, Muranaka H, Akinsola R, Billet S, Levi A, Abbas A, et al. Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Biomedicines. 2023; 11(5):1392. https://doi.org/10.3390/biomedicines11051392

Gong, Jun, Arsen Osipov, Jeremy Lorber, Mourad Tighiouart, Albert K. Kwan, Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Abrahm Levi, Anser Abbas, and et al. 2023. "Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol" Biomedicines 11, no. 5: 1392. https://doi.org/10.3390/biomedicines11051392

Gong, J., Osipov, A., Lorber, J., Tighiouart, M., Kwan, A. K., Muranaka, H., Akinsola, R., Billet, S., Levi, A., Abbas, A., Davelaar, J., Bhowmick, N., & Hendifar, A. E. (2023). Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Biomedicines, 11(5), 1392. https://doi.org/10.3390/biomedicines11051392